Cargando…

The Use of Liraglutide in Obese Patients With COVID-19: A Case Report

Introduction: In December 2019, a new type of coronavirus was discovered in Wuhan, China, characterized by a picture of atypical pneumonia composed of fever, dry cough and progressive dyspnea. Autopsy analyzes of patients with Covid-19 were performed, and hyperactivation of cytotoxic T cells was obs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanada, Taliê Zanchetta Buani, Knack, Rafael Silvestre, Knack, Renata Silvestre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090259/ http://dx.doi.org/10.1210/jendso/bvab048.075

Ejemplares similares

FRI063 Effectiveness Of Liraglutide In Treating Obesity And Improving Hepatic Steatosis
por: Alfadda, Assim Abdulaziz, et al.
Publicado: (2023)

OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial
por: Kelly, Aaron S, et al.
Publicado: (2020)

Preliminary results of clinical use of colchicine in COVID-19 treatment
por: Knack, Rafael Silvestre, et al.
Publicado: (2021)

MON-605 Serum CD163, but Not Gal-3, Predicts Response to Liraglutide Therapy in Obese Patients
por: Mat, Arimin, et al.
Publicado: (2020)

MON-591 Effect of Liraglutide Treatment on Proglucagon-Derived Peptides
por: Kim, Sun, et al.
Publicado: (2020)

LBODP002 Phase II Open-label Pilot Trial Of Liraglutide In Adolescents With Obesity After Vertical Sleeve Gastrectomy: Interim Results From 8-weeks Of Treatment
por: Fatima, Syeda Z, et al.
Publicado: (2022)

SAT-099 Liraglutide 3.0 mg as an Adjunct to Intensive Behavior Therapy in Individuals with Obesity: SCALE IBT 56-Week Randomized, Double-Blind, Placebo-Controlled Trial
por: Wadden, Thomas, et al.
Publicado: (2019)

Hashimoto’s thyroiditis following SARS-CoV-2 infection
por: Knack, Rafael Silvestre, et al.
Publicado: (2021)

MON-120 Effect of Weight Loss on Physical Function Measured by the 6-Minute Walking Distance Test in Individuals with Obesity: Results from the SCALE IBT Trial of Liraglutide 3.0 Mg
por: Rubino, Domenica, et al.
Publicado: (2019)

Obesity and Covid-19: A Major Mortality Risk in Patients Hospitalized With Covid-19
por: Rodriguez, Giovanna, et al.
Publicado: (2021)

SAT-097 Weight Loss With Liraglutide 3.0 Mg Versus Placebo For Individuals Who Adhere To The Trial Drug: A Secondary Analysis From SCALE IBT
por: Shaw Tronieri, Jena, et al.
Publicado: (2019)

SAT-105 Weight Loss As Determined By Adherence To Reduced Caloric Diet, Increased Physical Activity, Liraglutide 3.0 Mg and Placebo: A Sub-analysis Of The SCALE IBT Trial
por: Shaw Tronieri, Jena, et al.
Publicado: (2019)

Obesity Is Associated With Intensive Care Use and Duration of ICU Stay but Not Mortality Among 3246 Patients Hospitalized With COVID-19
por: Kang, Yu Mi, et al.
Publicado: (2021)

ODP591 Obesity and Weight Loss Apps in COVID-19 Era: Do They Help Both the Doctor and the Patient?
por: Lawrence, Rebecca, et al.
Publicado: (2022)

FRI044 Racial Differences In Outcomes Of Hospitalizations For COVID-19 With Morbid Obesity: Insights From The National Inpatient Sample
por: Gajjar, Rohan Ashwinbhai, et al.
Publicado: (2023)

LBODP004 The Impact Of Covid-19 On Obesity And Ultra-processed Food Intake In Adolescents And Young Adults: Interim Analysis From The PIE Study
por: Balhara, Maria
Publicado: (2022)

FRI043 The Double Pandemic Effect Of Obesity And COVID-19 Among United States Adult Hospitalizations: Outlining Hospitalization Outcomes Of A Synergistic Catastrophe
por: Shaka, Hafeez, et al.
Publicado: (2023)

MON-103 Chromosome 15q13.3 Microdeletion And MAGEL2 Gene Mutation In A Pediatric Patient With Extreme Obesity And Tall Stature: A Case Report
por: Duhame, Danielle, et al.
Publicado: (2019)

FRI042 Worsening Shortness Of Breath After A Mild Case Of Covid-19
por: Qureshi, Khurrum, et al.
Publicado: (2023)

FRI066 Treatment History And Comorbidities Reported By Patients With Hypothalamic Obesity Treated With Setmelanotide In A Phase 2 Trial
por: Roth, Christian L, et al.
Publicado: (2023)

ODP009 Obesity-related Conditions in Adults with Overweight and Obesity in the United States: A Cluster Analysis
por: Chiu, Kevin, et al.
Publicado: (2022)

SAT664 Obesity And Overweight Diagnosis, Physician Prescription And Patient Filling Of Anti-Obesity Medications In US
por: Ezendu, Kyrian, et al.
Publicado: (2023)

Dextroamphetamine Treatment for Children With Hypothalamic Obesity
por: van Schaik, Jiska, et al.
Publicado: (2021)

FRI083 Identifying Determinants Of Change In Physical Activity In Women With Obesity And Infertility Following The Obesity-Fertility Program
por: Gélinas, Myriam, et al.
Publicado: (2023)

Effects of Colchicine on Measures of Lipolysis in Adults With Obesity
por: Sarrafan-Chaharsoughi, Zahra, et al.
Publicado: (2021)

OR10-05 Improved Mental And Psychosocial Patient-Reported Outcomes Among People With Obesity Treated With Tirzepatide: Results From SURMOUNT-1 Study
por: Poon, Jiat Ling, et al.
Publicado: (2023)

MON-607 Very Low-Calorie Ketogenic Diet Modifies Visceral Adipose Tissue Distribution and Taxonomic Composition of Gut Microbiota in Obese Patients with Insulin Resistance Depending on Protein Source
por: Basciani, Sabrina, et al.
Publicado: (2020)

OR20-4 NMRI-metabolomics Variables Associated With The Metabolically-healthy Obese Phenotype And The Transitions Between Metabolically-healthy And Unhealthy Obesity Phenotypes.
por: Vargas-Vazquez, Arsenio, et al.
Publicado: (2019)

MON-584 Albuminuria and Obesity - Which Are the Associated Factors?
por: Costa, Cláudia Fernandes, et al.
Publicado: (2020)

The Contribution of Arachidonic Acid Metabolites EETs to Inflammation in Obesity
por: Mashayekhi, Mona, et al.
Publicado: (2021)

FRI046 Clinical Phenotyping Of Adults With Genetic Obesity
por: Welling, Mila Sofie, et al.
Publicado: (2023)

SAT-101 The Combination of Anti-Obesity Medications and Bariatric Surgery Can Be Effective in Resetting the Cerebral Adipostat in Individuals with Autism Suffering from Severe Obesity
por: Bhardwaj, Nakul, et al.
Publicado: (2019)

Anti-Obesity Medication Prescriptions by Race/Ethnicity and Use of an Interpreter in a Pediatric Weight Management Clinic
por: Bomberg, Eric M, et al.
Publicado: (2021)

SUN-110 The Role Of RasD2 In Metabolism And Obesity
por: Fong, Vincent, et al.
Publicado: (2019)

OR12-2 Obesity Induces Changes in T Cell Metabolism and Function
por: Alwarawrah, Yazan, et al.
Publicado: (2019)

SUN-594 Pubertal Timing and Hormonal Correlates in Male Obesity
por: De Schepper, Jean, et al.
Publicado: (2020)

MON-LB104 Update on Anti-Obesity Medical Devices
por: Heshmati, Hassan M
Publicado: (2020)

Impact of Morbid Obesity on Patients With Hypertriglyceridemia Induced Acute Pancreatitis
por: Pudasaini, Garima, et al.
Publicado: (2021)

Cancer Risk of Patients With Overweight and Obesity: A Predictive Model
por: Turchin, Alexander, et al.
Publicado: (2021)

The Pesticide Chlorpyrifos Promotes Obesity by Inhibiting Diet-Induced Thermogenesis
por: Wang, Bo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oh7eep8f3ola8fgktrlblr3fu5